Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Populum is a premium CBD wellness company that specializes in high-quality, hemp-derived products designed for daily use. Founded in 2016, the company distinguishes itself through a commitment to transparency, utilizing triple-lab testing for all its formulations to ensure purity and potency. Its product line includes full-spectrum CBD oils, topical balms, and pet supplements. In 2022, Populum was acquired by NuLeaf Naturals, another leader in the cannabinoid industry, to expand its market reach and product innovation. The brand continues to focus on providing accessible, science-backed hemp solutions for stress, sleep, and physical recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Populum.